FTSE 100 movers: M&S climbs on update; Glencore slips on downgrade
7th Apr 2016 13:04
(ShareCast News) - London's FTSE 100 index was down 0.1% to 6,154.99 at 1410 BST, although retailer M&S bucked the trend. Payments processor Worldpay was under pressure after private equity groups Advent International and Bain Capital sold a 12.5% stake in the company. Glencore fell after JP Morgan
Read moreLondon-listed pharmas rally as Pfizer-Allergan deal collapses
6th Apr 2016 10:20
(ShareCast News) - Shares in pharmaceuticals companies Shire, AstraZeneca and GlaxoSmithKline rallied on Wednesday as investors bet that the termination of Pfizer's agreement to buy Allergan might make the London-listed companies bid targets. US drug maker Pfizer said on Wednesday that its $160bn ag
Read moreTuesday broker round-up
29th Mar 2016 16:51
(ShareCast News) - Synthomer: Berenberg downgrades to hold with a target price of 345p. Next: Goldman Sachs downgrades to neutral, 6400p target, Canaccord downgrades to hold with a target price of 6025p, Deutsche Bank reiterates buy with a target of 6850p and Credit Suisse stays at underperform, 560
Read moreSanofi poaches top AstraZeneca scientist
29th Mar 2016 11:27
(ShareCast News) - Sanofi revealed it had poached one of AstraZeneca's top scientists on Tuesday, appointing Yong-Jun Liu as its new research head. The French drugmaker said Liu's appointment would take effect on 1 April, and he would report to its president of global research and development Elias
Read moreLondon pre-open: Stocks seen touch higher after Easter break
29th Mar 2016 07:44
(ShareCast News) - London stocks are set to open a touch higher on Tuesday as traders get back to their desks following the long Easter weekend. The FTSE 100 is seen starting six points higher than Friday's close at 6,113. Later on in the day, investors will eye a speech from Federal Reserve Chair
Read moreApproval in Japan for AstraZeneca lung cancer treatment
29th Mar 2016 07:18
(ShareCast News) - The Japanese Ministry of Health, Labour and Welfare delivered good news to AstraZeneca on Tuesday morning, approving the FTSE 100 drug company's Tagrisso (osimertinib) tablets for the treatment of patients with epidermal growth factor receptor (EGFR) T790M mutation-positive inoper
Read moreLondon pre-open: Stocks seen lower as investors continue to digest Brussels attacks
23rd Mar 2016 07:37
(ShareCast News) - London stocks were set to open lower on Tuesday following a mostly negative session in Asia as investors continue to digest the terror attacks in Brussels. The FTSE 100 is seen starting 25 points lower than Tuesday's close at 6,167. "While travel and hotel stocks took a bit of a
Read moreAstraZeneca stroke trials show Brilinta not effective
23rd Mar 2016 07:10
(ShareCast News) - AstraZeneca's Brilinta drug missed its target during a trial in stroke patients, proving less effective than aspirin. Clinical tests of Brilinta had been assessing efficacy of 90mg tablets taken twice daily compared to aspirin 100mg once daily in patients with acute ischaemic stro
Read moreTuesday broker round-up
15th Mar 2016 16:46
(ShareCast News) - Virgin Money: Goldman Sachs reiterates neutral with a target price of 450p and Berenberg stays at hold with a 400p target. Gem Diamonds: Panmure Gordon keeps at buy, 181p target and Finncap reiterates buy with a target of 270p. G4S: Credit Suisse reiterates neutral with a target
Read moreFTSE 100 movers: Miners gain but HSBC slumps on Bernstein note
29th Feb 2016 13:47
(ShareCast News) - London's FTSE 100 index was down 0.3% to 6,075.39 at 1525 GMT, as investors weighed up disappointment that the G20 meeting did not yield a coordinated stimulus effort against the People's Bank of China's move to cut the reserve requirement ratio. HSBC was in the red after Bernstei
Read moreAstraZeneca signs China licensing deal for Plendil
29th Feb 2016 08:27
(ShareCast News) - AstraZeneca has entered a licensing deal with China Medical System Holdings Ltd for the commercialisation rights in China to its hypertension medicine Plendil. Under the terms of the agreement, which does not include the transfer of any AstraZeneca employees or facilities, China M
Read moreSunday newspaper round-up: Pound, GSK, Sainsbury's, HSBC
28th Feb 2016 17:29
(ShareCast News) - Sterling will fall to $1.28 by the end of 2016, its lowest level against the US dollar in three decades, currency strategists have cautioned. If Britain votes to leave the European Union the fall will be even worse, the Sunday Telegraph reported that Deutsche Bank analysts saw a f
Read moreAstraZeneca buoyed by Oprhan recommendations for Acerta cancer drug
25th Feb 2016 08:59
(ShareCast News) - AstraZeneca has been buoyed by news that its acalabrutinib cancer treatment has been recommended for orphan drug status by the European Medicines Agency (EMA) for three forms of lymphoma. The EMA gave positive opinions for the acalabrutinib in the treatment of chronic lymphocytic
Read moreAstraZeneca gets European approval for Zurampic and Brilique
19th Feb 2016 07:14
(ShareCast News) - The European Commission has given AstraZeneca's Zurampic drug marketing authorisation for the treatment of gout in the European Union. It has been approved in combination with a xanthine oxidase inhibitor (XOI) to treat hyperuricemia in adult gout patients who have not achieved ta
Read moreLondon pre-open: Stocks seen higher as investors eye UK data, FOMC minutes
17th Feb 2016 07:16
(ShareCast News) - London stocks are expected to open higher on Wednesday following a positive close in the US, as investors look to a slew of UK data releases and the latest FOMC minutes. London's FTSE 100 is seen starting 15 points higher than Tuesday's close at 5,877. On the data front, the UK u
Read more